SUMMARY Sixty patients were treated with either acyclovir 3% ointment or idoxuridine 1% ointment 5 times a day in a stratified randomised double-blind clinical trial. The 2 antiviral agents were equally effective.
The biological activity of acyclovir having been confirmed in human viral disease, the next step was to compare the drug used in a more conventional manner to established antiviral chemotherapy. Here we report the results of a trial comparing the effects of acyclovir and idoxuridine (IDU) ointments on the rate of healing of herpetic corneal ulcers.
Patients and methods
Sixty consenting patients presenting with ulcerative herpetic keratitis were admitted to the trial. Patients were allocated to strata on the basis of clinical features likely to be significant in prognosis. The stratification factors were the type of ulcer, that is, geographic or dendritic, the size of the ulcer, whether the patient had received topical corticosteroids within the 3 weeks prior to presentation, and the degree of inflammatory reaction in the cornea and anterior chamber. Within these strata patients were randomly allocated to 1 of 2 treatment groups. One group received IDU 1% ointment 5 times a day until the epithelial defect had healed and then 3 times a day for 3 more days. The other group received acyclovir 3% ointment 5 times a day until the epithelial defect healed and then 3 times a day for a further 3 days. All patients received a drop of atropine 1% each day until healed. Neither the patient nor the ophthalmologist knew which treatment was being used, so that the trial was stratified, randomised, and double-blind.
Having begun treatment, patients were examined at the slit-lamp on alternate days. The point of healing was judged to have occurred when no epithelial defect was demonstrable with rose Bengal and fluorescein staining. 763 Douglas J. Coster, K. R. Wilhelmus, R. Michaud, and Barrie R. Jones
Results
Sixty patients were admitted to the trial. Fifty-four had dendritic and 6 had geographic (amoeboid) ulcers. Thirty received IDU and 30 received acyclovir. The distribution of patients is set out in Table 1 . One patient treated with acyclovir failed to present regularly for follow-up, though he responded favourably in that his geographic ulcer had healed when he returned 10 days after beginning therapy. He is not included in the analysis.
There were no treatment failures, nor were there any untoward reactions that necessitated withdrawal of therapy. One patient developed an allergic reaction that subsided on withdrawing the atropine drops.
The results were evaluated on the basis of the number of days it took the ulcers to heal in each group. The distribution of healing times for patients in both treatment groups is set out in Fig. 1 . A cumulative frequency curve indicating the pattern of healing in each group is displayed in Fig. 2 . Clearly the patterns are very similar, and a logrank analysis indicates that the difference between the Patients with marked inflammatory reaction in the corneal stroma and anterior chamber.
curves is likely to have occurred by change (P>0 05). When the geographic ulcers are excluded from the analysis the difference between the groups is even less (Fig. 3 ). 
